Raymond James Reiterates Strong Buy Rating on Boston Scientific (BSX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq rise in choppy trading as tech steadies, Micron results in focus
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Boston Scientific (BSX) PT Raised to $120 at BofA Securities
July 23, 2025 12:19 PM EDTBofA Securities analyst Travis Steed raised the price target on Boston Scientific (NYSE: BSX) to $120.00 (from $115.00) while maintaining a Buy rating.
The analyst comments "The adjusted income statement had a $100m impact in Q2 with the majority of this being inventory... More
